HEADER HORMONE/GROWTH FACTOR 03-OCT-00 1FYR TITLE DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL STRUCTURE OF TITLE 2 THE GRB2-SH2 AC-PYVNV COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: SH2 DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR PEPTIDE; COMPND 8 CHAIN: I, J, K, L; COMPND 9 FRAGMENT: RESIDUES 1356-1359 (RESIDUES 0-3 IN COORDINATES); COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: THE SEQUENCE YVNV IS ALSO FOUND IN OTHER PROTEINS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PGEX-2T; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 11 OCCURS NATURALLY IN HUMANS. KEYWDS GRB2, SH2 DOMAIN, PHOSPHOPEPTIDE, MET, DOMAIN SWAPPING, DIMERIZATION, KEYWDS 2 HORMONE-GROWTH FACTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.SCHIERING,E.CASALE,P.CACCIA,P.GIORDANO,C.BATTISTINI REVDAT 5 15-NOV-23 1FYR 1 REMARK REVDAT 4 09-AUG-23 1FYR 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1FYR 1 VERSN REVDAT 2 01-APR-03 1FYR 1 JRNL REVDAT 1 06-DEC-00 1FYR 0 JRNL AUTH N.SCHIERING,E.CASALE,P.CACCIA,P.GIORDANO,C.BATTISTINI JRNL TITL DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTAL JRNL TITL 2 STRUCTURE OF THE GRB2-SH2-AC-PYVNV COMPLEX. JRNL REF BIOCHEMISTRY V. 39 13376 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 11063574 JRNL DOI 10.1021/BI0012336 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 22403 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1100 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 22403 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3432 REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE : 0.3090 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 174 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3356 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.75000 REMARK 3 B22 (A**2) : 4.75000 REMARK 3 B33 (A**2) : -9.49000 REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.35 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.290 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.800 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.460 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 0.840 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.420 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : MASK REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 30.84 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FYR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-OCT-00. REMARK 100 THE DEPOSITION ID IS D_1000012024. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-APR-96 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.7 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22423 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1GRI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11% PEG 3350, 0.5M NACL, 0.1M MES/NAOH REMARK 280 PH 5.7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 91.73500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 38.80500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 38.80500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 137.60250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 38.80500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 38.80500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 45.86750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 38.80500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 38.80500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 137.60250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 38.80500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 38.80500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.86750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 91.73500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 8 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 PLEASE NOTE IT HAS NOT BEEN PROVEN THAT THE DOMAIN- REMARK 300 SWAPPED DIMER HAS BIOLOGICAL SIGNIFICANCE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -73.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, K REMARK 350 BIOMT1 1 0.000000 -1.000000 0.000000 38.80500 REMARK 350 BIOMT2 1 1.000000 0.000000 0.000000 -38.80500 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 -45.86750 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, L REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 38.80500 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 38.80500 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 45.86750 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, I, J REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -106.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, K, L REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 -77.61000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 183.47000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -70.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, K REMARK 350 BIOMT1 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 1.000000 0.000000 0.000000 -77.61000 REMARK 350 BIOMT3 1 0.000000 0.000000 -1.000000 183.47000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, I, J REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -67.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, J REMARK 350 BIOMT1 1 0.000000 1.000000 0.000000 77.61000 REMARK 350 BIOMT2 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 -1.000000 183.47000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, K, L REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 48 REMARK 465 SER A 49 REMARK 465 LYS A 50 REMARK 465 ASN A 51 REMARK 465 TYR A 52 REMARK 465 ILE A 53 REMARK 465 GLU A 54 REMARK 465 MET A 55 REMARK 465 LYS A 56 REMARK 465 PRO A 57 REMARK 465 GLN A 153 REMARK 465 VAL A 154 REMARK 465 PRO A 155 REMARK 465 GLN A 156 REMARK 465 GLN A 157 REMARK 465 PRO A 158 REMARK 465 THR A 159 REMARK 465 TYR A 160 REMARK 465 VAL A 161 REMARK 465 GLY B 48 REMARK 465 SER B 49 REMARK 465 LYS B 50 REMARK 465 ASN B 51 REMARK 465 TYR B 52 REMARK 465 ILE B 53 REMARK 465 GLU B 54 REMARK 465 GLN B 153 REMARK 465 VAL B 154 REMARK 465 PRO B 155 REMARK 465 GLN B 156 REMARK 465 GLN B 157 REMARK 465 PRO B 158 REMARK 465 THR B 159 REMARK 465 TYR B 160 REMARK 465 VAL B 161 REMARK 465 GLY C 48 REMARK 465 SER C 49 REMARK 465 LYS C 50 REMARK 465 ASN C 51 REMARK 465 TYR C 52 REMARK 465 ILE C 53 REMARK 465 GLU C 54 REMARK 465 GLN C 153 REMARK 465 VAL C 154 REMARK 465 PRO C 155 REMARK 465 GLN C 156 REMARK 465 GLN C 157 REMARK 465 PRO C 158 REMARK 465 THR C 159 REMARK 465 TYR C 160 REMARK 465 VAL C 161 REMARK 465 GLY D 48 REMARK 465 SER D 49 REMARK 465 LYS D 50 REMARK 465 ASN D 51 REMARK 465 TYR D 52 REMARK 465 ILE D 53 REMARK 465 GLU D 54 REMARK 465 MET D 55 REMARK 465 LYS D 56 REMARK 465 PRO D 57 REMARK 465 GLN D 153 REMARK 465 VAL D 154 REMARK 465 PRO D 155 REMARK 465 GLN D 156 REMARK 465 GLN D 157 REMARK 465 PRO D 158 REMARK 465 THR D 159 REMARK 465 TYR D 160 REMARK 465 VAL D 161 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASN A 103 OD1 REMARK 480 ARG A 149 CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 101 107.07 -164.81 REMARK 500 PRO B 59 10.14 -62.04 REMARK 500 PRO C 59 2.18 -65.39 REMARK 500 HIS C 135 29.94 -75.01 REMARK 500 ASN L 2 33.36 -95.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE I -1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE J -1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE K -1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE L -1 DBREF 1FYR A 50 161 UNP P29354 GRB2_HUMAN 50 161 DBREF 1FYR B 50 161 UNP P29354 GRB2_HUMAN 50 161 DBREF 1FYR C 50 161 UNP P29354 GRB2_HUMAN 50 161 DBREF 1FYR D 50 161 UNP P29354 GRB2_HUMAN 50 161 DBREF 1FYR I 0 3 UNP P08581 MET_HUMAN 1356 1359 DBREF 1FYR J 0 3 UNP P08581 MET_HUMAN 1356 1359 DBREF 1FYR K 0 3 UNP P08581 MET_HUMAN 1356 1359 DBREF 1FYR L 0 3 UNP P08581 MET_HUMAN 1356 1359 SEQADV 1FYR GLY A 48 UNP P08581 CLONING ARTIFACT SEQADV 1FYR SER A 49 UNP P08581 CLONING ARTIFACT SEQADV 1FYR GLY B 48 UNP P08581 CLONING ARTIFACT SEQADV 1FYR SER B 49 UNP P08581 CLONING ARTIFACT SEQADV 1FYR GLY C 48 UNP P08581 CLONING ARTIFACT SEQADV 1FYR SER C 49 UNP P08581 CLONING ARTIFACT SEQADV 1FYR GLY D 48 UNP P08581 CLONING ARTIFACT SEQADV 1FYR SER D 49 UNP P08581 CLONING ARTIFACT SEQADV 1FYR PTR I 0 UNP P08581 TYR 1356 MODIFIED RESIDUE SEQADV 1FYR PTR J 0 UNP P08581 TYR 1356 MODIFIED RESIDUE SEQADV 1FYR PTR K 0 UNP P08581 TYR 1356 MODIFIED RESIDUE SEQADV 1FYR PTR L 0 UNP P08581 TYR 1356 MODIFIED RESIDUE SEQRES 1 A 114 GLY SER LYS ASN TYR ILE GLU MET LYS PRO HIS PRO TRP SEQRES 2 A 114 PHE PHE GLY LYS ILE PRO ARG ALA LYS ALA GLU GLU MET SEQRES 3 A 114 LEU SER LYS GLN ARG HIS ASP GLY ALA PHE LEU ILE ARG SEQRES 4 A 114 GLU SER GLU SER ALA PRO GLY ASP PHE SER LEU SER VAL SEQRES 5 A 114 LYS PHE GLY ASN ASP VAL GLN HIS PHE LYS VAL LEU ARG SEQRES 6 A 114 ASP GLY ALA GLY LYS TYR PHE LEU TRP VAL VAL LYS PHE SEQRES 7 A 114 ASN SER LEU ASN GLU LEU VAL ASP TYR HIS ARG SER THR SEQRES 8 A 114 SER VAL SER ARG ASN GLN GLN ILE PHE LEU ARG ASP ILE SEQRES 9 A 114 GLU GLN VAL PRO GLN GLN PRO THR TYR VAL SEQRES 1 B 114 GLY SER LYS ASN TYR ILE GLU MET LYS PRO HIS PRO TRP SEQRES 2 B 114 PHE PHE GLY LYS ILE PRO ARG ALA LYS ALA GLU GLU MET SEQRES 3 B 114 LEU SER LYS GLN ARG HIS ASP GLY ALA PHE LEU ILE ARG SEQRES 4 B 114 GLU SER GLU SER ALA PRO GLY ASP PHE SER LEU SER VAL SEQRES 5 B 114 LYS PHE GLY ASN ASP VAL GLN HIS PHE LYS VAL LEU ARG SEQRES 6 B 114 ASP GLY ALA GLY LYS TYR PHE LEU TRP VAL VAL LYS PHE SEQRES 7 B 114 ASN SER LEU ASN GLU LEU VAL ASP TYR HIS ARG SER THR SEQRES 8 B 114 SER VAL SER ARG ASN GLN GLN ILE PHE LEU ARG ASP ILE SEQRES 9 B 114 GLU GLN VAL PRO GLN GLN PRO THR TYR VAL SEQRES 1 C 114 GLY SER LYS ASN TYR ILE GLU MET LYS PRO HIS PRO TRP SEQRES 2 C 114 PHE PHE GLY LYS ILE PRO ARG ALA LYS ALA GLU GLU MET SEQRES 3 C 114 LEU SER LYS GLN ARG HIS ASP GLY ALA PHE LEU ILE ARG SEQRES 4 C 114 GLU SER GLU SER ALA PRO GLY ASP PHE SER LEU SER VAL SEQRES 5 C 114 LYS PHE GLY ASN ASP VAL GLN HIS PHE LYS VAL LEU ARG SEQRES 6 C 114 ASP GLY ALA GLY LYS TYR PHE LEU TRP VAL VAL LYS PHE SEQRES 7 C 114 ASN SER LEU ASN GLU LEU VAL ASP TYR HIS ARG SER THR SEQRES 8 C 114 SER VAL SER ARG ASN GLN GLN ILE PHE LEU ARG ASP ILE SEQRES 9 C 114 GLU GLN VAL PRO GLN GLN PRO THR TYR VAL SEQRES 1 D 114 GLY SER LYS ASN TYR ILE GLU MET LYS PRO HIS PRO TRP SEQRES 2 D 114 PHE PHE GLY LYS ILE PRO ARG ALA LYS ALA GLU GLU MET SEQRES 3 D 114 LEU SER LYS GLN ARG HIS ASP GLY ALA PHE LEU ILE ARG SEQRES 4 D 114 GLU SER GLU SER ALA PRO GLY ASP PHE SER LEU SER VAL SEQRES 5 D 114 LYS PHE GLY ASN ASP VAL GLN HIS PHE LYS VAL LEU ARG SEQRES 6 D 114 ASP GLY ALA GLY LYS TYR PHE LEU TRP VAL VAL LYS PHE SEQRES 7 D 114 ASN SER LEU ASN GLU LEU VAL ASP TYR HIS ARG SER THR SEQRES 8 D 114 SER VAL SER ARG ASN GLN GLN ILE PHE LEU ARG ASP ILE SEQRES 9 D 114 GLU GLN VAL PRO GLN GLN PRO THR TYR VAL SEQRES 1 I 5 ACE PTR VAL ASN VAL SEQRES 1 J 5 ACE PTR VAL ASN VAL SEQRES 1 K 5 ACE PTR VAL ASN VAL SEQRES 1 L 5 ACE PTR VAL ASN VAL MODRES 1FYR PTR I 0 TYR O-PHOSPHOTYROSINE MODRES 1FYR PTR J 0 TYR O-PHOSPHOTYROSINE MODRES 1FYR PTR K 0 TYR O-PHOSPHOTYROSINE MODRES 1FYR PTR L 0 TYR O-PHOSPHOTYROSINE HET ACE I -1 3 HET PTR I 0 16 HET ACE J -1 3 HET PTR J 0 16 HET ACE K -1 3 HET PTR K 0 16 HET ACE L -1 3 HET PTR L 0 16 HETNAM ACE ACETYL GROUP HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 5 ACE 4(C2 H4 O) FORMUL 5 PTR 4(C9 H12 N O6 P) FORMUL 9 HOH *182(H2 O) HELIX 1 1 PRO A 66 LYS A 76 1 11 HELIX 2 2 SER A 127 HIS A 135 1 9 HELIX 3 3 PRO B 66 LYS B 76 1 11 HELIX 4 4 SER B 127 THR B 138 1 12 HELIX 5 5 PRO C 66 SER C 75 1 10 HELIX 6 6 SER C 127 HIS C 135 1 9 HELIX 7 7 PRO D 66 SER D 75 1 10 HELIX 8 8 SER D 127 HIS D 135 1 9 SHEET 1 A 4 PHE A 83 GLU A 87 0 SHEET 2 A 4 PHE A 95 PHE A 101 -1 N SER A 96 O ARG A 86 SHEET 3 A 4 ASP A 104 ARG A 112 -1 O ASP A 104 N PHE A 101 SHEET 4 A 4 TYR A 118 PHE A 119 -1 O PHE A 119 N LEU A 111 SHEET 1 B 3 PHE B 83 GLU B 87 0 SHEET 2 B 3 PHE B 95 PHE B 101 -1 N SER B 96 O ARG B 86 SHEET 3 B 3 ASP B 104 LYS B 109 -1 O ASP B 104 N PHE B 101 SHEET 1 C 2 LEU B 111 ARG B 112 0 SHEET 2 C 2 TYR B 118 PHE B 119 -1 O PHE B 119 N LEU B 111 SHEET 1 D 4 PHE C 61 LYS C 64 0 SHEET 2 D 4 PHE C 83 GLU C 87 1 O ILE C 85 N PHE C 62 SHEET 3 D 4 PHE C 95 PHE C 101 -1 N SER C 96 O ARG C 86 SHEET 4 D 4 ASP C 104 LYS C 109 -1 O ASP C 104 N PHE C 101 SHEET 1 E 2 LEU C 111 ARG C 112 0 SHEET 2 E 2 TYR C 118 PHE C 119 -1 O PHE C 119 N LEU C 111 SHEET 1 F 4 ARG C 149 ASP C 150 0 SHEET 2 F 4 ALA D 82 GLU D 87 1 N PHE D 83 O ARG C 149 SHEET 3 F 4 PHE D 95 PHE D 101 -1 N SER D 96 O ARG D 86 SHEET 4 F 4 ASP D 104 LYS D 109 -1 O ASP D 104 N PHE D 101 SHEET 1 G 2 LEU D 111 ARG D 112 0 SHEET 2 G 2 TYR D 118 PHE D 119 -1 O PHE D 119 N LEU D 111 LINK C ACE I -1 N PTR I 0 1555 1555 1.33 LINK C PTR I 0 N VAL I 1 1555 1555 1.33 LINK C ACE J -1 N PTR J 0 1555 1555 1.34 LINK C PTR J 0 N VAL J 1 1555 1555 1.46 LINK C ACE K -1 N PTR K 0 1555 1555 1.34 LINK C PTR K 0 N VAL K 1 1555 1555 1.43 LINK C ACE L -1 N PTR L 0 1555 1555 1.34 LINK C PTR L 0 N VAL L 1 1555 1555 1.36 SITE 1 AC1 1 ARG A 67 SITE 1 AC2 2 ARG B 67 HOH J1039 SITE 1 AC3 1 ARG C 67 SITE 1 AC4 2 ARG D 67 HOH L1031 CRYST1 77.610 77.610 183.470 90.00 90.00 90.00 P 43 21 2 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012885 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012885 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005450 0.00000